Thurston, Springer, Miller, Herd & Titak, Inc. Jazz Pharmaceuticals PLC Transaction History
Thurston, Springer, Miller, Herd & Titak, Inc.
- $330 Million
- Q3 2024
A detailed history of Thurston, Springer, Miller, Herd & Titak, Inc. transactions in Jazz Pharmaceuticals PLC stock. As of the latest transaction made, Thurston, Springer, Miller, Herd & Titak, Inc. holds 65 shares of JAZZ stock, worth $8,178. This represents 0.0% of its overall portfolio holdings.
Number of Shares
65
Previous 64
1.56%
Holding current value
$8,178
Previous $6,000
16.67%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding JAZZ
# of Institutions
512Shares Held
57.5MCall Options Held
188KPut Options Held
133K-
Black Rock Inc. New York, NY6.15MShares$773 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.11MShares$768 Million0.01% of portfolio
-
Lsv Asset Management Chicago, IL2.49MShares$314 Million0.6% of portfolio
-
Pacer Advisors, Inc. Malvern, PA2.1MShares$264 Million0.56% of portfolio
-
State Street Corp Boston, MA1.95MShares$245 Million0.01% of portfolio
About Jazz Pharmaceuticals plc
- Ticker JAZZ
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,680,700
- Market Cap $7.89B
- Description
- Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...